Seeking Alpha13/11/2026 10:30:45

NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M

NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M

31 min ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Talphera outlines plan to seek FDA agreement to end NEPHRO enrollment by Dec. 31, 2026, while raising Niyad peak U.S. sales view to over $200M

11 min ago

Talphera, Inc. (TLPH) Q3 2026 Earnings Call Transcript

13 min ago

WidePoint Corporation (WYY) Q3 2026 Earnings Call Transcript

13 min ago

EDF: Time For An Upgrade For This CEF

14 min ago